Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma

por Saraswati, Sarita, Alhaider, Abdulqader, Abdelgadir, Abdelgalil Mohamed, Tanwer, Pooja, Korashy, Hesham M.
Publicado 2019